Banner

Nuclear Medicine Global Market Report 2022 – By Type (Diagnostic, Therapeutic), By Application (Cardiology, Lymphomia, Thyroid, Neurology, Oncology, Other Application), By End-User (Hospitals and Clinics, Diagnostic Centers, Other End Users) – Market Size, Trends, And Global Forecast 2022-2026

Starting Price : $5000.00 | Pages : 175 | Published : November 2022 | SKU CODE : | Delivery Time: 2-3 business days | Format :


The nuclear medicine market consists of sales of nuclear medicine and related products by entities (organizations, sole traders, and partnerships) that are used to assess the health of organs or tissue or to identify and remove any diseased or damaged organs or tissue. Nuclear medicine refers to a specialised area of radiology that uses radioactive material inside the body to inspect the overall health condition of the concerned patient. This branch of radiology is frequently used to identify and treat abnormalities that first appear very early in the course of a disease, such as thyroid cancer.

The main types of nuclear medicine are diagnostic and therapeutic. A diagnostic is an examination to identify a person's distinct areas of strength and weakness to identify a condition, disease, or illness. The applications involved cardiology, lymphoma, thyroid, neurology, oncology, and other applications. The end-users included hospitals and clinics, diagnostic centers, and other end-users.

The nuclear medicine market research report is one of a series of new reports from The Business Research Company that provides nuclear medicine market statistics, including nuclear medicine industry global market size, regional shares, competitors with a nuclear medicine market share, detailed nuclear medicine market segments, market trends and opportunities, and any further data you may need to thrive in the nuclear medicine industry. This nuclear medicine market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The global nuclear medicine market size is expected to grow from $6.00 billion in 2021 to $6.77 billion in 2022 at a compound annual growth rate (CAGR) of 12.9%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic, at least in the short term. The war between these two countries has led to economic sanctions on multiple countries, surge in commodity prices, and supply chain disruptions, effecting many markets across the globe. The nuclear medicine market is expected to grow to $11.20 billion in 2026 at a CAGR of 13.4%.

The increasing constancy and prevalence of cardiovascular disease (CVD) and cancer are expected to propel the growth of the nuclear medicine market going forward. Cardiovascular diseases (CVDs) are a group of heart and blood vessel disorders, and cancer is a disease in which cells grow out of control and spread to other body parts. Nuclear cardiac imaging can help diagnose cardiac diseases more quickly. Nuclear medicine therapy is a method to treat cancer that might be used with or after other therapy options, such as surgery and chemotherapy. As a result, the growing constancy and prevalence of cardiovascular disease and cancer increase the demand for the nuclear medicine market. For instance, in 2020, according to GLOBOCAN, a US-based cancer observatory, there were 19.29k new cancer cases in the world in the year 2020, and 28.88k cases are anticipated by 2040. Further, in 2019, according to the World Health Organization (WHO), a Switzerland-based international organisation responsible for public health, estimates that 17.9 million people worldwide died from cardiovascular diseases (CVDs) in the year 2019, accounting for 32% of all fatalities. 85% of these fatalities were caused by heart attack and stroke. Therefore, the growing constancy and prevalence of cardiovascular diseases and cancer are driving the nuclear medicine market. 

Product innovation is the key trend gaining popularity in the nuclear medicine market. Major companies operating in the nuclear medicine market are focused on developing new innovative products to strengthen their position. For instance, in March 2021, GE Healthcare, a US-based company that deals with nuclear medicine, launched Star Guide, a new nuclear medicine system to assist in advancing precision health and theragnostics. StarGuide uses the most recent developments in Cadmium Zinc Telluride (CZT) technology to assist providers in exploring and better understanding the patient's condition, enhancing patient outcomes throughout the continuum of care. It has unique features such as digital focus detectors and 360-degree imaging of the system that are intended to support improved theragnostic capabilities in nuclear medicine and advanced precision health.

In August 2019, Bracco Imaging, an Italy-based healthcare company, acquired Blue Earth Diagnostics for an undisclosed amount. This acquisition will enable both companies to realise their full potential by significantly broadening the combined portfolio in precision medicine and personalised diagnostics while expanding the wide range of nuclear oncology imaging solutions in the Urology segment and other specialties. Blue Earth Diagnostics is a UK-based company operating in nuclear medicine.

Major players in the nuclear medicine market are Bracco Imaging S.P.A., Lantheus Medical Imaging Inc., NTP Radioisotopes SOC Ltd, Eckert & Ziegler Group, Jubilant Pharma LLC, Australian Nuclear Science & Technology Organization, Cardinal Health Inc., GE Healthcare, Curium Pharma7, Advanced Accelerator Applications, Nordion Inc., The Institute for Radioelements, Eczacbas-Monrol, Siemens Healthineers AG, and Cambridge Isotope Laboratories Inc.

North America was the largest region in the nuclear medicine market in 2021. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this nuclear medicine market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, the Middle East, and Africa.

The countries covered in the nuclear medicine market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, the UK, and the USA.

The global nuclear medicine market is segmented -

1) By Type: Diagnostic, Therapeutic

2) By Application: Cardiology, Lymphoma, Thyroid, Neurology, Oncology, Other Application

3) By End-User: Hospitals and Clinics, Diagnostic Centers, Other End Users

    Table Of Contents

    1. Executive Summary

    2. Nuclear Medicine Market Characteristics

    3. Nuclear Medicine Market Trends And Strategies

    4. Nuclear Medicine Market - Macro Economic Scenario

    4.1. COVID-19 Impact On Nuclear Medicine Market

    4.2. Ukraine-Russia War Impact On Nuclear Medicine Market

    4.3. Impact Of High Inflation On Nuclear Medicine Market

    5. Nuclear Medicine Market Size And Growth

    5.1. Global Nuclear Medicine Historic Market, 2016-2021, $ Billion

    5.1.1. Drivers Of The Market

    5.1.2. Restraints On The Market

    5.2. Global Nuclear Medicine Forecast Market, 2021-2026F, 2031F, $ Billion

    5.2.1. Drivers Of The Market

    5.2.2. Restraints On the Market

    6. Nuclear Medicine Market Segmentation

    6.1. Global Nuclear Medicine Market, Segmentation By Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

    Diagnostic

    Therapeutic

    6.2. Global Nuclear Medicine Market, Segmentation By Application, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

    Cardiology

    Lymphomia

    Thyroid

    Neurology

    Oncology

    Other Application

    6.3. Global Nuclear Medicine Market, Segmentation By End-User, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

    Hospitals and Clinics

    Diagnostic Centers

    Other End Users

    7. Nuclear Medicine Market Regional And Country Analysis

    7.1. Global Nuclear Medicine Market, Split By Region, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

    7.2. Global Nuclear Medicine Market, Split By Country, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

    8. Asia-Pacific Nuclear Medicine Market

    8.1. Asia-Pacific Nuclear Medicine Market Overview

    Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

    8.2. Asia-Pacific Nuclear Medicine Market, Segmentation By Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

    8.3. Asia-Pacific Nuclear Medicine Market, Segmentation By End-User, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

    9. China Nuclear Medicine Market

    9.1. China Nuclear Medicine Market Overview

    9.2. China Nuclear Medicine Market, Segmentation By Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F,$ Billion

    9.3. China Nuclear Medicine Market, Segmentation By End-User, Historic and Forecast, 2016-2021, 2021-2026F, 2031F,$ Billion

    10. India Nuclear Medicine Market

    10.1. India Nuclear Medicine Market, Segmentation By Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

    10.2. India Nuclear Medicine Market, Segmentation By End-User, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

    11. Japan Nuclear Medicine Market

    11.1. Japan Nuclear Medicine Market, Segmentation By Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

    11.2. Japan Nuclear Medicine Market, Segmentation By End-User, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

    12. Australia Nuclear Medicine Market

    12.1. Australia Nuclear Medicine Market, Segmentation By Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

    12.2. Australia Nuclear Medicine Market, Segmentation By End-User, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

    13. Indonesia Nuclear Medicine Market

    13.1. Indonesia Nuclear Medicine Market, Segmentation By Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

    13.2. Indonesia Nuclear Medicine Market, Segmentation By End-User, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

    14. South Korea Nuclear Medicine Market

    14.1. South Korea Nuclear Medicine Market, Segmentation By Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

    14.2. South Korea Nuclear Medicine Market, Segmentation By End-User, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

    15. Western Europe Nuclear Medicine Market

    15.1. Western Europe Nuclear Medicine Market Overview

    15.2. Western Europe Nuclear Medicine Market, Segmentation By Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

    15.3. Western Europe Nuclear Medicine Market, Segmentation By End-User, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

    16. UK Nuclear Medicine Market

    16.1. UK Nuclear Medicine Market, Segmentation By Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

    16.2. UK Nuclear Medicine Market, Segmentation By End-User, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

    17. Germany Nuclear Medicine Market

    17.1. Germany Nuclear Medicine Market, Segmentation By Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

    17.2. Germany Nuclear Medicine Market, Segmentation By End-User, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

    18. France Nuclear Medicine Market

    18.4. France Nuclear Medicine Market, Segmentation By Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

    18.5. France Nuclear Medicine Market, Segmentation By End-User, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

    19. Eastern Europe Nuclear Medicine Market

    19.1. Eastern Europe Nuclear Medicine Market Overview

    19.2. Eastern Europe Nuclear Medicine Market, Segmentation By Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

    19.3. Eastern Europe Nuclear Medicine Market, Segmentation By End-User, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

    20. Russia Nuclear Medicine Market

    20.1. Russia Nuclear Medicine Market, Segmentation By Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

    20.2. Russia Nuclear Medicine Market, Segmentation By End-User, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

    21. North America Nuclear Medicine Market

    21.1. North America Nuclear Medicine Market Overview

    21.2. North America Nuclear Medicine Market, Segmentation By Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

    21.3. North America Nuclear Medicine Market, Segmentation By End-User, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

    22. USA Nuclear Medicine Market

    22.1. USA Nuclear Medicine Market Overview

    22.2. USA Nuclear Medicine Market, Segmentation By Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

    22.3. USA Nuclear Medicine Market, Segmentation By End-User, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

    23. South America Nuclear Medicine Market

    23.1. South America Nuclear Medicine Market Overview

    23.2. South America Nuclear Medicine Market, Segmentation By Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

    23.3. South America Nuclear Medicine Market, Segmentation By End-User, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

    24. Brazil Nuclear Medicine Market

    24.1. Brazil Nuclear Medicine Market, Segmentation By Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

    24.2. Brazil Nuclear Medicine Market, Segmentation By End-User, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

    25. Middle East Nuclear Medicine Market

    25.1. Middle East Nuclear Medicine Market Overview

    25.2. Middle East Nuclear Medicine Market, Segmentation By Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

    25.3. Middle East Nuclear Medicine Market, Segmentation By End-User, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

    26. Africa Nuclear Medicine Market

    26.1. Africa Nuclear Medicine Market Overview

    26.2. Africa Nuclear Medicine Market, Segmentation By Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

    26.3. Africa Nuclear Medicine Market, Segmentation By End-User, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

    27. Nuclear Medicine Market Competitive Landscape And Company Profiles

    27.1. Nuclear Medicine Market Competitive Landscape

    27.2. Nuclear Medicine Market Company Profiles

    27.2.1. Bracco Imaging S.P.A.

    27.2.1.1. Overview

    27.2.1.2. Products and Services

    27.2.1.3. Strategy

    27.2.1.4. Financial Performance

    27.2.2. Lantheus Medical Imaging Inc.

    27.2.2.1. Overview

    27.2.2.2. Products and Services

    27.2.2.3. Strategy

    27.2.2.4. Financial Performance

    27.2.3. NTP Radioisotopes SOC Ltd

    27.2.3.1. Overview

    27.2.3.2. Products and Services

    27.2.3.3. Strategy

    27.2.3.4. Financial Performance

    27.2.4. Eckert & Ziegler Group

    27.2.4.1. Overview

    27.2.4.2. Products and Services

    27.2.4.3. Strategy

    27.2.4.4. Financial Performance

    27.2.5. Jubilant Pharma LLC

    27.2.5.1. Overview

    27.2.5.2. Products and Services

    27.2.5.3. Strategy

    27.2.5.4. Financial Performance

    28. Key Mergers And Acquisitions In The Nuclear Medicine Market

    29. Nuclear Medicine Market Future Outlook and Potential Analysis

    30. Appendix

    30.1. Abbreviations

    30.2. Currencies

    30.3. Historic And Forecast Inflation Rates

    30.4. Research Inquiries

    30.5. The Business Research Company

    30.6. Copyright And Disclaimer

List Of Tables

    Table 1: Global Historic Market Growth, 2016-2021, $ Billion
  • Table 2: Global Forecast Market Growth, 2021-2026F, 2031F, $ Billion
  • Table 3: Global Nuclear Medicine Market, Segmentation By Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Table 4: Global Nuclear Medicine Market, Segmentation By Application, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Table 5: Global Nuclear Medicine Market, Segmentation By End-User, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Table 6: Global Nuclear Medicine Market, Split By Region, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Table 7: Global Nuclear Medicine Market, Split By Country, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Table 8: Asia-Pacific, Nuclear Medicine Market, Segmentation By Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Table 9: Asia-Pacific, Nuclear Medicine Market, Segmentation By End-User, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Table 10: China, Nuclear Medicine Market, Segmentation By Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Table 11: China, Nuclear Medicine Market, Segmentation By End-User, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Table 12: India, Nuclear Medicine Market, Segmentation By Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Table 13: India, Nuclear Medicine Market, Segmentation By End-User, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Table 14: Japan, Nuclear Medicine Market, Segmentation By Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Table 15: Japan, Nuclear Medicine Market, Segmentation By End-User, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Table 16: Australia, Nuclear Medicine Market, Segmentation By Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Table 17: Australia, Nuclear Medicine Market, Segmentation By End-User, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Table 18: Indonesia, Nuclear Medicine Market, Segmentation By Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Table 19: Indonesia, Nuclear Medicine Market, Segmentation By End-User, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Table 20: South Korea, Nuclear Medicine Market, Segmentation By Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Table 21: South Korea, Nuclear Medicine Market, Segmentation By End-User, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Table 22: Western Europe, Nuclear Medicine Market, Segmentation By Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Table 23: Western Europe, Nuclear Medicine Market, Segmentation By End-User, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Table 24: UK, Nuclear Medicine Market, Segmentation By Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Table 25: UK, Nuclear Medicine Market, Segmentation By End-User, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Table 26: Germany, Nuclear Medicine Market, Segmentation By Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Table 27: Germany, Nuclear Medicine Market, Segmentation By End-User, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Table 28: France, Nuclear Medicine Market, Segmentation By Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Table 29: France, Nuclear Medicine Market, Segmentation By End-User, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Table 30: Eastern Europe, Nuclear Medicine Market, Segmentation By Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Table 31: Eastern Europe, Nuclear Medicine Market, Segmentation By End-User, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Table 32: Russia, Nuclear Medicine Market, Segmentation By Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Table 33: Russia, Nuclear Medicine Market, Segmentation By End-User, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Table 34: North America, Nuclear Medicine Market, Segmentation By Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Table 35: North America, Nuclear Medicine Market, Segmentation By End-User, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Table 36: USA, Nuclear Medicine Market, Segmentation By Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Table 37: USA, Nuclear Medicine Market, Segmentation By End-User, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Table 38: South America, Nuclear Medicine Market, Segmentation By Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Table 39: South America, Nuclear Medicine Market, Segmentation By End-User, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Table 40: Brazil, Nuclear Medicine Market, Segmentation By Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Table 41: Brazil, Nuclear Medicine Market, Segmentation By End-User, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Table 42: Middle East, Nuclear Medicine Market, Segmentation By Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Table 43: Middle East, Nuclear Medicine Market, Segmentation By End-User, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Table 44: Africa, Nuclear Medicine Market, Segmentation By Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Table 45: Africa, Nuclear Medicine Market, Segmentation By End-User, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Table 46: Bracco Imaging S.P.A. Financial Performance
  • Table 47: Lantheus Medical Imaging Inc. Financial Performance
  • Table 48: NTP Radioisotopes SOC Ltd Financial Performance
  • Table 49: Eckert & Ziegler Group Financial Performance
  • Table 50: Jubilant Pharma LLC Financial Performance

List Of Figures

    Figure 1: Global Historic Market Growth, 2016-2021, $ Billion
  • Figure 2: Global Forecast Market Growth, 2021-2026F, 2031F, $ Billion
  • Figure 3: Global Nuclear Medicine Market, Segmentation By Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Figure 4: Global Nuclear Medicine Market, Segmentation By Application, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Figure 5: Global Nuclear Medicine Market, Segmentation By End-User, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Figure 6: Global Nuclear Medicine Market, Split By Region, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Figure 7: Global Nuclear Medicine Market, Split By Country, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Figure 8: Asia-Pacific, Nuclear Medicine Market, Segmentation By Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Figure 9: Asia-Pacific, Nuclear Medicine Market, Segmentation By End-User, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Figure 10: China, Nuclear Medicine Market, Segmentation By Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Figure 11: China, Nuclear Medicine Market, Segmentation By End-User, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Figure 12: India, Nuclear Medicine Market, Segmentation By Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Figure 13: India, Nuclear Medicine Market, Segmentation By End-User, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Figure 14: Japan, Nuclear Medicine Market, Segmentation By Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Figure 15: Japan, Nuclear Medicine Market, Segmentation By End-User, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Figure 16: Australia, Nuclear Medicine Market, Segmentation By Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Figure 17: Australia, Nuclear Medicine Market, Segmentation By End-User, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Figure 18: Indonesia, Nuclear Medicine Market, Segmentation By Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Figure 19: Indonesia, Nuclear Medicine Market, Segmentation By End-User, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Figure 20: South Korea, Nuclear Medicine Market, Segmentation By Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Figure 21: South Korea, Nuclear Medicine Market, Segmentation By End-User, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Figure 22: Western Europe, Nuclear Medicine Market, Segmentation By Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Figure 23: Western Europe, Nuclear Medicine Market, Segmentation By End-User, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Figure 24: UK, Nuclear Medicine Market, Segmentation By Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Figure 25: UK, Nuclear Medicine Market, Segmentation By End-User, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Figure 26: Germany, Nuclear Medicine Market, Segmentation By Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Figure 27: Germany, Nuclear Medicine Market, Segmentation By End-User, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Figure 28: France, Nuclear Medicine Market, Segmentation By Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Figure 29: France, Nuclear Medicine Market, Segmentation By End-User, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Figure 30: Eastern Europe, Nuclear Medicine Market, Segmentation By Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Figure 31: Eastern Europe, Nuclear Medicine Market, Segmentation By End-User, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Figure 32: Russia, Nuclear Medicine Market, Segmentation By Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Figure 33: Russia, Nuclear Medicine Market, Segmentation By End-User, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Figure 34: North America, Nuclear Medicine Market, Segmentation By Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Figure 35: North America, Nuclear Medicine Market, Segmentation By End-User, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Figure 36: USA, Nuclear Medicine Market, Segmentation By Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Figure 37: USA, Nuclear Medicine Market, Segmentation By End-User, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Figure 38: South America, Nuclear Medicine Market, Segmentation By Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Figure 39: South America, Nuclear Medicine Market, Segmentation By End-User, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Figure 40: Brazil, Nuclear Medicine Market, Segmentation By Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Figure 41: Brazil, Nuclear Medicine Market, Segmentation By End-User, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Figure 42: Middle East, Nuclear Medicine Market, Segmentation By Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Figure 43: Middle East, Nuclear Medicine Market, Segmentation By End-User, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Figure 44: Africa, Nuclear Medicine Market, Segmentation By Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Figure 45: Africa, Nuclear Medicine Market, Segmentation By End-User, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Figure 46: Bracco Imaging S.P.A. Financial Performance
  • Figure 47: Lantheus Medical Imaging Inc. Financial Performance
  • Figure 48: NTP Radioisotopes SOC Ltd Financial Performance
  • Figure 49: Eckert & Ziegler Group Financial Performance
  • Figure 50: Jubilant Pharma LLC Financial Performance
What Is The Cosmetic Surgery Market Overview In 2022?
Global Macular Degeneration Treatment Market 2022 – Market Opportunities And Strategies
Global Feminine Hygiene Products Market 2022 – Market Opportunities And Strategies
How Will The Eclinical Solutions Market Grow In 2022?
The Business Research Company offers the synthetic biology market research report 2022 with industry size, share, segments and market growth
The Business Research Company offers the medical image analysis software market research report 2022 with industry size, share, segments and market growth
The Business Research Company offers the healthcare distribution market research report 2022 with industry size, share, segments and market growth
The Business Research Company offers the biohacking market research report 2022 with industry size, share, segments and market growth
Animal Medicine Global Market Report 2022 – By Type (Veterinary Pharmaceuticals, Feed Additives), By Type of Animal (Livestock, Companion Animals), By End-Use (Veterinary Hospitals, Pharmacies And Drug Stores, Veterinary Clinics) – Market Size, Trends, And Global Forecast 2022-2026
View Report
Small Animal Imaging (In-Vivo) Global Market Report 2022 – By Component (Micro-MRI, Optical Imaging, Nuclear Imaging, Other Components), By Application (Monitoring Treatment Response, Bio Distribution, Determining Drug or Target Engagement, Cancer Cell Detection, Biomarkers, Longitudinal Studies, Epigenetics), By End User (Veterinary Clinics, Veterinary Hospitals, Veterinary Institutes and Research Centers) – Market Size, Trends, And Global Forecast 2022-2026
View Report
Nuclear Imaging Devices And Equipment Global Market Report 2022 – By Product Type (SPECT systems, PET systems, Planar Scintigraphy), By Application (Oncology, Cardiology, Neurology), By End User (Hospitals, Imaging Centers, Academic & Research Institutes) – Market Size, Trends, And Global Forecast 2022-2026
View Report
Precision Medicine Global Market Report 2022 – By Technology (Big Data Analytics, Bioinformatics, Gene Sequencing, Drug Discovery, Companion Diagnostics), By Application (Oncology, Respiratory Diseases, Central Nervous System Disorders, Immunology, Genetic Diseases), By End-User ( Hospitals And Clinics, Pharmaceuticals, Diagnostic Companies, Healthcare And IT Firms)– Market Size, Trends, And Global Forecast 2022-2026
View Report
Nanomedicine Global Market Report 2022 – By Type (Nanoparticles, Nanoshells, Nanotubes, Nanodevices), By Modality (Diagnostics, Treatments), By Application(Clinical Oncology, Infectious Diseases, Clinical Cardiology, Orthopedics) – Market Size, Trends, And Global Forecast 2022-2026
View Report
Regenerative Medicine For Cartilage Market 2022 – By Treatment Modality ( Cell-Based, Non-Cell-Based), By Treatment Type ( Palliative, Intrinsic Repair Stimulus, Others Skin Resurfacing ), By Site (Knee Cartilage Repair, Ribs), By Application (Hyaline Cartilage Repair and Regeneration, Elastic Cartilage Repair and Regeneration, Fibrous Cartilage Repair and Regeneration), By End-User: Ambulatory Surgical Centers, Hospitals & Clinics), And By Region, Opportunities And Strategies – Global Forecast To 2031
View Report
Aesthetic Medicine Global Market Report 2022 – By Product (Facial Aesthetic Products, Body Contouring Devices, Cosmetic Implants, Hair Removal Devices, Skin Aesthetic Devices, Tattoo Removal Devices, Thread Lift Products, Physician-dispensed Cosmeceuticals and Skin Lighteners, Physician-dispensed Eyelash Products, Nail Treatment Laser Devices), By Procedure Type (Invasive Procedures, Non-Invasive Procedures), By End-User (Clinics, Hospitals, and Medical Spas, Beauty Centres, Home Care) – Market Size, Trends, And Global Forecast 2022-2026
View Report
Breast Imaging Devices Market 2022 - By Procedure Type (Tomosynthesis, Breast Ultrasound, Breast MRI, Mammography, Nuclear Imaging), By Technology (Ionizing, Non-Ionizing), By End-User (Hospitals And Clinics, Breast Care Centers, Diagnostic Imaging Centers), And By Region, Opportunities And Strategies – Global Forecast To 2030
View Report